Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells
Authors
Keywords
Protein tyrosine phosphatase 1B (PTP1B), Astragaloside IV (AST IV), Insulin resistance, Lipid metabolism
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 268, Issue -, Pages 113556
Publisher
Elsevier BV
Online
2020-11-04
DOI
10.1016/j.jep.2020.113556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold
- (2019) Dongfeng Zhang et al. BIOORGANIC CHEMISTRY
- Pharmacophore-based drug design for potential AChE inhibitors from Traditional Chinese Medicine Database
- (2018) Yingying Jiang et al. BIOORGANIC CHEMISTRY
- Camellia euphlebia flower extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis in HepG2 cells
- (2018) Dongye He et al. European Journal of Integrative Medicine
- A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway
- (2018) Zhou Yang et al. Food & Function
- EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition
- (2018) Yashi Mi et al. Food & Function
- Research review on the pharmacological effects of astragaloside IV
- (2016) Lei Li et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway
- (2016) RONGFENG ZHU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Effect of Astragalus membranaceus (Fisch) Bunge extract on streptozocin-induced diabetic in rats
- (2016) Mei-ling Huo et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- Sasa quelpaertensisandp-Coumaric Acid Attenuate Oleic Acid-Induced Lipid Accumulation in HepG2 Cells
- (2013) Jeong-Hwan KIM et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Dock/Nck facilitates PTP61F/PTP1B regulation of insulin signalling
- (2011) Chia-Lun Wu et al. BIOCHEMICAL JOURNAL
- PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro
- (2011) Yi-ming Ma et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
- (2011) Ning Zhang et al. MOLECULES
- PTP1B: a double agent in metabolism and oncogenesis
- (2010) Shu-Chin Yip et al. TRENDS IN BIOCHEMICAL SCIENCES
- Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin
- (2009) Lin Lv et al. PHYTOTHERAPY RESEARCH
- Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition
- (2008) V.S. Muthusamy et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFαin 3T3-L1 adipocytes
- (2008) Boren Jiang et al. PHYTOTHERAPY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now